Dr. Hendrie’s clinical and research interests include nonmalignant blood disorders, leukemia, lymphoma, multiple myeloma and myelodysplastic syndrome. He is a board-certified hematologist at Seattle Cancer Care Alliance and a University of Washington School of Medicine associate professor of hematology and medicine. As an expert who studies and treats rare diseases, he works with a broad range of patients, some of whom participate in clinical trials. Dr. Hendrie has been a part of the ECD Global Alliance community since 2016.
Paul C. Hendrie, MD, PhD
